Rifaximin Prophylaxis for Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome in Cirrhotic Patients
NCT05621005
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
104
Enrollment
OTHER
Sponsor class
Conditions
Ascites Infection
Interventions
DRUG:
Rifaximin 550 milligram Oral Tablet [XIFAXAN]
Sponsor
Samar Atef Sebaweh Mohammed